Motoyuki Sugai Selected Research

Motoyuki Sugai Research Topics

Disease

11	Infections 03/2022 - 01/2006
5	Impetigo (Impetigo Contagiosa) 01/2019 - 05/2002
5	Staphylococcal Scalded Skin Syndrome (Ritter's Disease) 08/2011 - 05/2002
4	Staphylococcal Food Poisoning 08/2017 - 07/2014
3	Foodborne Diseases 07/2021 - 10/2015
3	Blister (Bulla) 04/2011 - 05/2002
2	Septic Shock (Toxic Shock Syndrome) 01/2022 - 10/2015
2	Cross Infection (Nosocomial Infection) 01/2021 - 04/2020
2	Bacteremia 01/2021 - 02/2020
2	Atopic Dermatitis (Atopic Eczema) 01/2020 - 12/2017
2	Atherosclerotic Plaque (Atheroma) 10/2017 - 01/2017
2	Periodontal Diseases (Periodontal Disease) 12/2003 - 11/2003
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Fever (Fevers) 01/2021
1	Endocarditis 01/2021
1	Dermatitis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Mitral Valve Prolapse 01/2021
1	Pyelonephritis 01/2021
1	Dysbiosis 12/2020
1	Malocclusion (Crossbite) 12/2020
1	Periodontitis 12/2020
1	Aspiration Pneumonia 01/2020
1	Stroke (Strokes) 01/2020
1	Cellulitis 01/2020
1	Infarction (Infarctions) 01/2020
1	Abscess 01/2018
1	Bovine Mastitis 10/2015
1	Fibrosis (Cirrhosis) 11/2013
1	Sepsis (Septicemia) 09/2013
1	Mouth Neoplasms (Oral Cancer) 01/2013
1	Opportunistic Infections (Opportunistic Infection) 01/2013
1	Pyoderma 11/2010
1	Pseudomonas Infections 03/2007
1	Skin Diseases (Skin Disease) 10/2005
1	Necrosis 11/2003
1	Bacterial Infections (Bacterial Infection) 07/2003
1	Persistent Infection 04/2003

Drug/Important Bio-Agent (IBA)

6	ExfoliatinsIBA 08/2011 - 05/2002
5	Pharmaceutical PreparationsIBA 03/2022 - 03/2007
4	Virulence Factors (Pathogenicity Factors)IBA 04/2011 - 04/2003
4	Desmoglein 1IBA 04/2011 - 05/2002
3	Enterotoxins (Enterotoxin)IBA 07/2021 - 10/2015
2	Meropenem (Merrem)FDA LinkGeneric 01/2021 - 09/2013
2	CytokinesIBA 12/2017 - 11/2003
2	polysaccharide intercellular adhesinIBA 10/2017 - 01/2017
2	Staphylococcal enterotoxin HIBA 08/2017 - 11/2015
2	Proteins (Proteins, Gene)FDA Link 11/2015 - 05/2009
2	spleen fibrinolytic proteinase (human) (SFP)IBA 11/2015 - 07/2014
2	DesmogleinsIBA 08/2011 - 10/2005
2	Cell Adhesion MoleculesIBA 08/2011 - 11/2010
2	cytolethal distending toxinIBA 12/2003 - 04/2003
1	SterolsIBA 03/2022
1	Third Generation CephalosporinsIBA 01/2022
1	homocysteine-thiolactone-nicotinamide (ST 22)IBA 01/2022
1	GlucocorticoidsIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	beta-Lactamases (beta-Lactamase)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	carbapenemaseIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	SuperantigensIBA 01/2020
1	endolysinIBA 01/2019
1	Polysaccharides (Glycans)IBA 10/2017
1	Staphylococcal enterotoxin AIBA 08/2017
1	EmeticsIBA 10/2015
1	Messenger RNA (mRNA)IBA 10/2015
1	CoagulaseIBA 07/2014
1	CollagenIBA 11/2013
1	Imipenem FDA Link 09/2013
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	Peptide Hydrolases (Proteases)FDA Link 03/2010
1	Serine (L-Serine)FDA Link 05/2009
1	Peptides (Polypeptides)IBA 01/2006
1	Neutralizing AntibodiesIBA 04/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2003
1	InterleukinsIBA 11/2003
1	Interleukin-6 (Interleukin 6)IBA 11/2003
1	CathelicidinsIBA 07/2003
1	Antimicrobial PeptidesIBA 07/2003
1	Desmoglein 3IBA 05/2002
1	Cadherins (E-Cadherin)IBA 05/2002

Therapy/Procedure

2	Therapeutics 01/2021 - 11/2013
2	Lasers (Laser) 02/2020 - 05/2016
1	Vascular Access Devices (Arterial Line) 07/2021
1	Mitral Valve Annuloplasty 01/2021
1	Fixed Orthodontic Appliances 12/2020
1	Gastrostomy 01/2020
1	Catheters 01/2020
1	Long-Term Care 01/2020
1	Kidney Transplantation 01/2018
1	Aftercare (After-Treatment) 01/2013